Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical germline genetic testing for melanoma.

The Lancet. Oncology - 1 May 2004

Hansen Christopher B, Wadge Lisa M, Lowstuter Katrina, Boucher Kenneth, Leachman Sancy A

Abstract excerpt

Clinical genetic testing for mutations in CDKN2A (cyclin-dependent kinase inhibitor 2A), a melanoma susceptibility gene, is now available. The International Melanoma Genetics Consortium advocates that genetic testing for CDKN2A should be done only as part of a research protocol. Experience with genetic testing for other cancer-susceptibility genes indicates that CDKN2A testing has enormous potential for the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cutaneous Melanoma Detection and Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinase Inhibitor p16

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Melanoma

Share to Pedigree

Share to Skin Neoplasms

Source

Identifiers

PMID: 15120668
DOI: 10.1016/S1470-2045(04)01469-X

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical germline genetic testing for melanoma.PMID 15120668Read ↗

Genetic testing for melanoma predisposition: current challenges.Semantic proximity Read ↗

Genetic testing for familial melanoma.Semantic proximity Read ↗

Genetic testing in hereditary melanoma.Semantic proximity Read ↗

Clinical applications of melanoma genetics.Semantic proximity Read ↗

Melanoma genetics: an update on risk-associated genes.Semantic proximity Read ↗

[Recommendations for genetic testing and management of individuals genetically at-risk of cutaneous melanoma].Semantic proximity Read ↗

Genetic Testing in the Multidisciplinary Management of Melanoma.Semantic proximity Read ↗

Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium.Semantic proximity Read ↗

Germline Non-CDKN2A Variants in Melanoma and Associated Hereditary Cancer SyndromesSemantic proximity Read ↗

Identification, genetic testing, and management of hereditary melanoma.Semantic proximity Read ↗

The genetics of cutaneous melanoma.Semantic proximity Read ↗

Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of CDKN2A Pathogenic VariantsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.